HRTX (Heron Therapeutics) Net earnings per share growth this year

HRTX (Heron Therapeutics) - company brandmark

The implementation of eco-friendly production and wastewater treatment standards at Heron Therapeutics (HRTX) is reflected in the volatility of earnings per share compared to last year. The value -12.40 indicates the current level of this metric. Such an approach has strengthened the brand's authority in the pain management sector, while clinical superiority over opioids has enabled the company to maintain significant pricing power for its drugs.

Earnings per share growth in current year: Heron (HRTX) for 07/04/2022 - 11/18/2026

Financial and market metric breakdowns for Heron (HRTX)

- stock quotes and analyst forecast:
Summary company analysis:HRTX Heron Therapeutics, Inc.
Signature product of Heron Therapeutics, Inc.

The annual growth rate of earnings per share measures the efficiency of generating net income per unit of capital, allowing investors to assess the sustainability of operating profit without the influence of one-off factors. By analyzing the current EPS YoY growth rate, one can see how the medical community's confidence in Heron Therapeutics (HRTX) products converts into fundamental business growth and long-term investment attractiveness.

Key competitors

Earnings per share growth this year INCY|Earnings per share growth in current year Hutchison MediPharma|Net earnings per share growth this year nuvationbio.com (NUVB)|Earnings per share growth in current year Day One Biopharmaceuticals Inc (DAWN)|MNPR - Earnings per share growth rate in current year|Earnings per share growth in current year Inhibrx Biosciences Inc INBX|I-Mab - Earnings per share growth in current year|FENC - Earnings per share growth in current year|Earnings per share growth rate in current year Nuvectis Pharma, Inc.|CHRS: Earnings growth in current year|Net earnings per share change in current year Corbus Pharma CRBP|Net earnings per share growth this year CRDF|Earnings per share growth rate in current year BeyondSpring Inc. BYSI|Net earnings per share growth this year BCAB (BioAtla Inc)|LIXT (Lixte Biotechnology Holdings, Inc.) - Earnings per share increase in current year|Citius Pharmaceuticals, Inc. - Net earnings per share growth this year|Net earnings per one share growth for the current year CLRB (Cellectar Biosciences, Inc.)|BioLineRx Corp - Earnings growth in current year|Earnings per share increase in current year CANF (Can-Fite BioPharma, Ltd.)|APRE: Earnings growth in current year|Earnings per share growth rate in current year Kazia (KZIA)|Earnings per share growth in current year silexion.com|NCNA: Earnings per share increase in current year|Earnings growth in current year CMRX|Earnings growth in current year Cyclacel, Inc. (CYCC)|Earnings per share growth in current year G1 Therapeutics Inc. GTHX|KRON (Kronos Bio) - Earnings per share trend in current year|KTRA: Net earnings per share growth this year|Earnings per share growth rate in current year Oncternal Therapeutics Inc|Portage Biotech (PRTG) - Earnings per share growth in current year